News

Abbott Defeats Whistleblower Suit Over Diabetic Supplies Bills
A whistleblower’s False Claims Act suit filed in 2021 alleging fraudulent diabetic supplies billing by Arriva Medical LLC, ...
Zacks Investment Research on MSN1d
BBNX Stock May Gain From Abbott Deal to Advance iLet Integration
Beta Bionics, Inc. BBNX recently entered into a strategic agreement with Abbott Laboratories ABT to integrate its iLet Bionic ...
Is Abbott Laboratories' (NYSE:ABT) Stock's Recent Performance A Reflection Of Its Financial Health?
Most readers would already know that Abbott Laboratories' (NYSE:ABT) stock increased by 5.3% over the past three months. Since the market usually pay for a company’s long-term financial health, we ...
Drug Delivery Business1d
Abbott Diabetes head talks Medtronic partnership, exciting times ahead
For many, a partnership between Abbott and Medtronic, two medtech giants and frequent competitors, would have seemed unlikely ...
The Zacks Analyst Blog Highlights Meta, Palantir, Abbott Laboratories, SandRidge and CompX
META, PLTR and ABT lead this week's Zacks blog as AI growth, strong pipelines and solid earnings drive investor interest.
Abbott Laboratories stock outperforms competitors despite losses on the day
Shares of Abbott Laboratories ABT slipped 1.29% to $132.28 Tuesday, on what proved to be an all-around dismal trading session ...